Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - Merck & Co., Inc. (NYSE:MRK)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Options | Financials | Reports
Upcoming Events
Oct  1Dividend payment of $0.35
Location
P.O. Box 100, One Merck Drive
Whitehouse Station, NJ 08889
Phone: (908) 423-1000
Fax: (908) 735-1253
Employees (last reported count): 69,300
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Major Drugs
Company Websites
 ·Home Page
 ·Investor Relations
 ·Employment
 ·Divisions
 ·Yahoo! Category

 ·Search Yahoo! for related links...

Index Membership
 ·Dow Industrials
 ·S&P 500
Ownership
·Insider and 5%+ Owners: 1%
·Over the last 6 months:
 · one insider buy; 3,000  shares
 · 4 insider sells; 43.0K shares
  (0.2% of insider shares)
·Institutional: 57% (57% of float)
(2,933 institutions)
·Net Inst. Buying: 13.9M shares (+1.06%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
Merck & Co., Inc. is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a broad range of human and animal health products, directly and through its joint ventures, and provides pharmaceutical benefit services through Merck-Medco Managed Care, L.L.C. (Merck-Medco). The Company's operations are principally managed on a products and services basis and are comprised of two reportable segments, Merck Pharmaceutical, which includes products marketed either directly or through joint ventures, and Merck-Medco. Merck Pharmaceutical products consist of therapeutic agents, sold by prescription, for the treatment of human disorders. Merck-Medco revenues are derived from the filling and management of prescriptions and health management programs.
More from Market Guide: Expanded Business Description

Financial Summary
Merck and Co., Inc. is a pharmaceutical company that discovers, develops, produces and markets human/animal health products and services. Merck also provides pharmaceutical benefit services. For the six months ended 6/30/01, sales rose 27% to $23.24 billion. Net income rose 8% to $3.47 billion. Results reflect strong growth in worldwide human health sales, and other newer and established products, partially offset by higher materials and production costs.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

Raymond Gilmartin, 60
Chairman, Pres, CEO
$3.0M--  
Judy Lewent, 52
CFO, Exec. VP
1.1M$3.8M
David Anstice, 52
Pres, The Americas and U.S. Human Health
1.1M18.5M
Paul Bell, 55
Pres of Human Health-Asia Pacific
--  --  
Richard Clark, 55
Pres, Merck-Medco Managed Care, L.L.C.
--  --  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NYSE:MRKAs of 31-Aug-2001
Price and Volume
52-Week Low
on 12-July-2001
$60.35 
Recent Price$65.10 
52-Week High
on 30-Nov-2000
$96.688
Beta0.55 
Daily Volume (3-month avg)5.50M
Daily Volume (10-day avg)4.79M
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-5.9%
52-Week Change
relative to S&P500
+26.2%
Share-Related Items
Market Capitalization$149.0B
Shares Outstanding2.29B
Float2.27B
Dividends & Splits
Annual Dividend (indicated)$1.40 
Dividend Yield2.15%
Last Split: 2 for 1 on 17-Feb-1999
Per-Share Data
Book Value (mrq)$6.46 
Earnings (ttm)$3.02 
Earnings (mrq)$0.78 
Sales (ttm)$19.32 
Cash (mrq)$1.73 
Valuation Ratios
Price/Book (mrq)10.07 
Price/Earnings (ttm)21.56 
Price/Sales (ttm)3.37 
Income Statements
Sales (ttm)$45.3B
EBITDA (ttm)$11.5B
Income available to common (ttm)$7.07B
Profitability
Profit Margin (ttm)15.6%
Operating Margin (ttm)22.3%
Fiscal Year
Fiscal Year EndsDec 31
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)17.92%
Return on Equity (ttm)50.03%
Financial Strength
Current Ratio (mrq)1.12 
Debt/Equity (mrq)0.64 
Total Cash (mrq)$3.96B
Short Interest
As of 8-Aug-2001
Shares Short20.5M
Percent of Float0.9%
Shares Short
(Prior Month)
20.1M
Short Ratio3.49 
Daily Volume5.88M
See Profile Help for a description of each item above;   K = thousands;   M = millions;   B = billions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.